News

Video

Putting Quality of Life into Perspective During CML Treatment

Author(s):

Patients with chronic myeloid leukemia should be upfront with their care team about how treatment side effects are affecting their daily functioning.

When discussing side effects from chronic myeloid leukemia (CML) treatment with the health care team, it is essential that patients state how their daily activities are affected, according to Claire Saxton.

In an interview at the 2024 American Society of Clinical Oncology Annual Meeting, Saxton, who is the executive vice president of Insights and Impact at Cancer Support Community, discussed the importance of quality of life while patients with CML undergo treatment.

“When you put things really in the perspective of how is this affecting your everyday life, your treatment team will be much better able to make sure that whatever treatment that you're on, it's the one that is giving you the best quality of life,” she said during an interview with CURE® at the conference.

WATCH MORE: 3 Questions to Ask Doctors After a CML Diagnosis

Transcript:

So, in the long term, the treatment journey really is how do we keep you having as few symptoms and side effects and as good a quality of life as possible. And so, being really clear with your treatment team [is important].

My fatigue means that I can't do some of my favorite things. … The fact that I have diarrhea means that I can't take the bus to work anymore.

When you put things really in the perspective of how is this affecting your everyday life, your treatment team will be much better able to make sure that whatever treatment that you're on, it's the one that is giving you the best quality of life.

Editor's Note: This program was made possible with support from Novartis Pharmaceuticals.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
image of gerds
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Related Content